Sanofi India Ltd
NSE:SANOFI

Watchlist Manager
Sanofi India Ltd Logo
Sanofi India Ltd
NSE:SANOFI
Watchlist
Price: 6 135.3501 INR -0.77%
Market Cap: 141.3B INR
Have any thoughts about
Sanofi India Ltd?
Write Note

Sanofi India Ltd
Common Stock

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Sanofi India Ltd
Common Stock Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Common Stock CAGR 3Y CAGR 5Y CAGR 10Y
Sanofi India Ltd
NSE:SANOFI
Common Stock
â‚ą230m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Common Stock
â‚ą834m
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Common Stock
â‚ą1.6B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
0%
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Common Stock
â‚ą2.4B
CAGR 3-Years
0%
CAGR 5-Years
0%
CAGR 10-Years
1%
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Common Stock
â‚ą1.7B
CAGR 3-Years
26%
CAGR 5-Years
15%
CAGR 10-Years
7%
M
Mankind Pharma Ltd
NSE:MANKIND
Common Stock
â‚ą400.6m
CAGR 3-Years
0%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Sanofi India Ltd
Glance View

Market Cap
141.3B INR
Industry
Pharmaceuticals

Sanofi India Ltd., a prominent name in the pharmaceutical landscape, operates as a subsidiary of Sanofi S.A., the global healthcare giant headquartered in France. Its roots in India trace back to the early 1950s when it began importing and distributing vaccines. Over the decades, Sanofi India has evolved into a comprehensive provider of high-quality drugs, contributing significantly to the nation’s healthcare ecosystem. The company focuses primarily on therapeutic segments such as diabetes, cardiovascular diseases, oncology, and vaccines, boasting a robust portfolio of prescription medicines and over-the-counter products. By leveraging a vast network of healthcare professionals and engaging in continuous clinical research and development, Sanofi India ensures its position at the forefront of medical innovation, adhering to a global strategy of patient-oriented solutions and a commitment to improving health outcomes. Sanofi India's revenue model revolves around its diversified product portfolio, addressing a spectrum of critical health areas. The company generates income through the sale of its flagship products, which include insulin for diabetes management, anti-allergy medications, and innovative therapies for rare diseases, among others. While the domestic market plays a crucial role in its financial framework, Sanofi India also taps into international markets, exporting its high-quality pharmaceutical products across borders. The profitability of the company is further bolstered by its commitment to research and development, enabling it to introduce new drugs and therapies, thus continually expanding its market share. By maintaining strong distribution channels and fostering collaborations with medical institutions and regulatory bodies, Sanofi India ensures its products reach a broad consumer base, perpetuating its growth trajectory in the competitive pharmaceutical scene.

SANOFI Intrinsic Value
3 356.1891 INR
Overvaluation 45%
Intrinsic Value
Price

See Also

What is Sanofi India Ltd's Common Stock?
Common Stock
230m INR

Based on the financial report for Sep 30, 2024, Sanofi India Ltd's Common Stock amounts to 230m INR.

What is Sanofi India Ltd's Common Stock growth rate?
Common Stock CAGR 10Y
0%

Over the last year, the Common Stock growth was 0%.

Back to Top